Venture Life Group EBIT per Share
The EBIT per Share of Venture Life Group (VLG.L) as of Aug 20, 2026 is 0.02 GBP. In the previous year, EBIT per Share was 0.02 GBP — a change of 53.46% (higher).
Get this data via API
Financial Data API
EBIT per Share
0.02GBP
YoY
53.46%
Last updated:
EBIT per Share of Venture Life Group is 2026 0.02 GBP. EBIT per Share of Venture Life Group was 2025 0.02 GBP. It decreases by 53.46% higher compared to the previous year.
Access this data via the Eulerpool API
Venture Life Group Stock analysis
What does Venture Life Group do? The Venture Life Group PLC was founded in 2010 and is based in the United Kingdom. This company operates in the health and wellness industry and specializes in the development, manufacturing, and marketing of lifestyle products.
Venture Life's business model is based on developing products that can simplify and enhance people's everyday lives. This includes not only dietary supplements and medical devices, but also beauty and skincare products, as well as insect repellents.
The company is divided into various divisions, each focusing on different products. Venture Life Europe, the company's main pillar, focuses on dietary supplements and medical devices. This includes products such as sterile wound dressings and blood glucose monitors. The Southern Europe division specializes in dermatology products and insect repellents. In North America, Venture Life operates through its subsidiary Biokosmes, specializing in beauty and skincare products. Other divisions of the company, such as Nordic Life Science and Farma Mediterranea, produce dietary supplements and collagen products.
The company offers a wide range of products, including products like Just for Tummies, which are designed to support the immune and digestive systems, and Dentyl pH, which promotes lasting oral hygiene. Another product range from Venture Life is UltraDEX, which focuses on tongue and dental health, as well as oral care. Another product is the insect repellent Mosi-Guard, which is offered in various forms such as lotion, spray, and roll-on.
In recent years, Venture Life has also made acquisitions to strengthen its presence in specific markets and expand its product range. These acquisitions include UltraDex, a company focused on oral hygiene, and PharmaSource, a supplier of pharmaceutical raw materials.
Under the leadership of Jerry Randall, Venture Life has developed an experienced management team and a strong strategy for expanding into new markets and product categories. The company has an extensive network of customers and distribution partners and has built its reputation on high-quality products and excellent customer service.
Overall, Venture Life Group PLC is an innovative company with a wide range of products that focuses on improving its customers' daily lives. With a strong strategy and experienced leadership team, the company has established a good position in the industry and looks optimistically towards the future. Venture Life Group is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Venture Life Group stock
EBIT per Share of Venture Life Group is 0.02 GBP in 2026.
EBIT per Share of Venture Life Group changed from 0.02 GBP to 0.02 GBP, representing a 53.46% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Venture Life Group since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Venture Life Group
All Key Metrics — Venture Life Group
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth